» Articles » PMID: 19679274

Emerging Concepts in Neural Stem Cell Research: Autologous Repair and Cell-based Disease Modelling

Overview
Journal Lancet Neurol
Specialty Neurology
Date 2009 Aug 15
PMID 19679274
Citations 39
Authors
Affiliations
Soon will be listed here.
Abstract

The increasing availability of human pluripotent stem cells provides new prospects for neural-replacement strategies and disease-related basic research. With almost unlimited potential for self-renewal, the use of human embryonic stem cells (ESCs) bypasses the restricted supply and expandability of primary cells that has been a major bottleneck in previous neural transplantation approaches. Translation of developmental patterning and cell-type specification techniques to human ESC cultures enables in vitro generation of various neuronal and glial cell types. The derivation of stably proliferating neural stem cells from human ESCs further facilitates standardisation and circumvents the problem of batch-to-batch variations commonly encountered in "run-through" protocols, which promote terminal differentiation of pluripotent stem cells into somatic cell types without defined intermediate precursor stages. The advent of cell reprogramming offers an opportunity to translate these advances to induced pluripotent stem cells, thereby enabling the generation of neurons and glia from individual patients. Eventually, reprogramming could provide a supply of autologous neural cells for transplantation, and could lead to the establishment of cellular model systems of neurological diseases.

Citing Articles

Cell membrane-targeting NIR fluorescent probes with large Stokes shifts for ultralong-term transplanted neural stem cell tracking.

Chen J, Li D, Li H, Zhu K, Shi L, Fu X Front Bioeng Biotechnol. 2023; 11:1139668.

PMID: 36845195 PMC: 9948019. DOI: 10.3389/fbioe.2023.1139668.


Human mesenchymal amniotic fluid stem cells reveal an unexpected neuronal potential differentiating into functional spinal motor neurons.

Gaggi G, Di Credico A, Guarnieri S, Mariggio M, Di Baldassarre A, Ghinassi B Front Cell Dev Biol. 2022; 10:936990.

PMID: 35938174 PMC: 9354810. DOI: 10.3389/fcell.2022.936990.


Next-generation disease modeling with direct conversion: a new path to old neurons.

Traxler L, Edenhofer F, Mertens J FEBS Lett. 2019; 593(23):3316-3337.

PMID: 31715002 PMC: 6907729. DOI: 10.1002/1873-3468.13678.


A robust vitronectin-derived peptide for the scalable long-term expansion and neuronal differentiation of human pluripotent stem cell (hPSC)-derived neural progenitor cells (hNPCs).

Varun D, Srinivasan G, Tsai Y, Kim H, Cutts J, Petty F Acta Biomater. 2016; 48:120-130.

PMID: 27989923 PMC: 5235981. DOI: 10.1016/j.actbio.2016.10.037.


In Vivo Reprogramming for CNS Repair: Regenerating Neurons from Endogenous Glial Cells.

Li H, Chen G Neuron. 2016; 91(4):728-738.

PMID: 27537482 PMC: 5466364. DOI: 10.1016/j.neuron.2016.08.004.